Want to see PBH full AI Analyst Report?
Prestige Consumer Healthcare (PBH) Ratios
Prestige Consumer Healthcare Ratios
PBH's free cash flow for Q1 2027 was $67.08M. For the 2027 fiscal year, PBH's free cash flow was decreased by $-3.70M and operating cash flow was $70.79M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.57 | 4.20 | 3.20 | 2.44 | 2.04 |
| Quick Ratio | 2.25 | 2.82 | 2.02 | 1.43 | 1.21 |
| Cash Ratio | 0.53 | 0.92 | 0.40 | 0.36 | 0.19 |
| Solvency Ratio | 0.13 | 0.16 | 0.14 | -0.03 | 0.11 |
| Operating Cash Flow Ratio | 2.13 | 2.36 | 2.13 | 1.43 | 1.81 |
| Short-Term Operating Cash Flow Coverage | 86.28 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -1.23B | $ -1.12B | $ -1.29B | $ -1.51B | $ -1.80B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.29 | 0.31 | 0.34 | 0.41 | 0.41 |
| Debt-to-Equity Ratio | 0.55 | 0.57 | 0.69 | 0.94 | 0.95 |
| Debt-to-Capital Ratio | 0.36 | 0.36 | 0.41 | 0.49 | 0.49 |
| Long-Term Debt-to-Capital Ratio | 0.34 | 0.35 | 0.40 | 0.48 | 0.48 |
| Financial Leverage Ratio | 1.88 | 1.85 | 2.00 | 2.32 | 2.33 |
| Debt Service Coverage Ratio | 5.82 | 6.14 | 4.57 | 0.28 | 4.69 |
| Interest Coverage Ratio | 7.31 | 7.07 | 5.10 | -0.32 | 5.13 |
| Debt to Market Cap | 0.35 | 0.23 | 0.32 | 0.43 | 0.55 |
| Interest Debt Per Share | 22.45 | 21.97 | 24.25 | 28.79 | 31.25 |
| Net Debt to EBITDA | 2.96 | 2.61 | 2.92 | 166.19 | 4.12 |
| Profitability Margins | |||||
| Gross Profit Margin | 52.78% | 55.76% | 55.49% | 55.45% | 57.11% |
| EBIT Margin | 27.54% | 29.16% | 30.50% | -2.19% | 30.06% |
| EBITDA Margin | 30.41% | 31.82% | 33.22% | 0.70% | 33.02% |
| Operating Profit Margin | 28.42% | 29.60% | 30.43% | -1.99% | 30.36% |
| Pretax Profit Margin | 23.65% | 24.98% | 24.53% | -8.33% | 24.15% |
| Net Profit Margin | 17.48% | 18.86% | 18.60% | -7.30% | 18.90% |
| Continuous Operations Profit Margin | 17.48% | 18.86% | 18.60% | -7.30% | 18.90% |
| Net Income Per EBT | 73.90% | 75.51% | 75.84% | 87.64% | 78.25% |
| EBT Per EBIT | 83.22% | 84.39% | 80.61% | 418.98% | 79.55% |
| Return on Assets (ROA) | 5.36% | 6.31% | 6.31% | -2.45% | 5.60% |
| Return on Equity (ROE) | 10.08% | 11.70% | 12.65% | -5.69% | 13.02% |
| Return on Capital Employed (ROCE) | 9.03% | 10.22% | 10.70% | -0.70% | 9.35% |
| Return on Invested Capital (ROIC) | 6.65% | 7.70% | 8.10% | -0.61% | 7.30% |
| Return on Tangible Assets | 28.54% | 37.04% | 44.53% | -17.00% | 51.99% |
| Earnings Yield | 6.63% | 5.02% | 5.87% | -2.63% | 7.72% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.67 | 5.86 | 6.37 | 6.75 | 7.80 |
| Payables Turnover | 22.56 | 26.59 | 12.85 | 8.01 | 8.36 |
| Inventory Turnover | 3.23 | 3.41 | 3.61 | 3.10 | 3.87 |
| Fixed Asset Turnover | 6.36 | 8.90 | 12.60 | 12.60 | 11.03 |
| Asset Turnover | 0.31 | 0.33 | 0.34 | 0.34 | 0.30 |
| Working Capital Turnover Ratio | 3.34 | 3.79 | 4.60 | 5.92 | 7.31 |
| Cash Conversion Cycle | 161.15 | 155.73 | 130.01 | 126.25 | 97.36 |
| Days of Sales Outstanding | 64.34 | 62.33 | 57.34 | 54.06 | 46.79 |
| Days of Inventory Outstanding | 112.99 | 107.12 | 101.08 | 117.78 | 94.23 |
| Days of Payables Outstanding | 16.18 | 13.72 | 28.40 | 45.58 | 43.66 |
| Operating Cycle | 177.33 | 169.45 | 158.42 | 171.83 | 141.02 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 5.32 | 5.06 | 5.00 | 4.61 | 5.17 |
| Free Cash Flow Per Share | 5.09 | 4.90 | 4.81 | 4.45 | 4.98 |
| Dividend Paid and CapEx Coverage Ratio | 23.05 | 30.58 | 26.07 | 29.51 | 26.96 |
| Capital Expenditure Coverage Ratio | 23.05 | 30.58 | 26.07 | 29.51 | 26.96 |
| Operating Cash Flow Coverage Ratio | 0.25 | 0.24 | 0.22 | 0.17 | 0.17 |
| Operating Cash Flow to Sales Ratio | 0.24 | 0.22 | 0.22 | 0.20 | 0.24 |
| Free Cash Flow Yield | 8.58% | 5.69% | 6.71% | 7.10% | 9.41% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 15.08 | 19.90 | 17.04 | -37.96 | 12.96 |
| Price-to-Sales (P/S) Ratio | 2.64 | 3.76 | 3.17 | 2.77 | 2.45 |
| Price-to-Book (P/B) Ratio | 1.52 | 2.33 | 2.15 | 2.16 | 1.69 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 11.65 | 17.56 | 14.90 | 14.08 | 10.63 |
| Price-to-Operating Cash Flow Ratio | 11.15 | 16.99 | 14.33 | 13.60 | 10.24 |
| Price-to-Earnings Growth (PEG) Ratio | -1.67 | 7.62 | -0.05 | 0.27 | 0.52 |
| Enterprise Value Multiple | 11.64 | 14.42 | 12.46 | 562.96 | 11.54 |
| Enterprise Value | 3.85B | 5.22B | 4.66B | 4.43B | 4.14B |
| EV to EBITDA | 11.64 | 14.42 | 12.46 | 562.96 | 11.54 |
| EV to Sales | 3.54 | 4.59 | 4.14 | 3.93 | 3.81 |
| EV to Free Cash Flow | 15.64 | 21.45 | 19.47 | 19.97 | 16.54 |
| EV to Operating Cash Flow | 14.96 | 20.75 | 18.72 | 19.30 | 15.93 |
| Tangible Book Value Per Share | -20.50 | -19.88 | -23.98 | -28.51 | -33.78 |
| Shareholders’ Equity Per Share | 38.95 | 36.92 | 33.26 | 29.01 | 31.39 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.26 | 0.24 | 0.24 | 0.12 | 0.22 |
| Revenue Per Share | 22.47 | 22.89 | 22.62 | 22.61 | 21.62 |
| Net Income Per Share | 3.93 | 4.32 | 4.21 | -1.65 | 4.09 |
| Tax Burden | 0.74 | 0.76 | 0.76 | 0.88 | 0.78 |
| Interest Burden | 0.86 | 0.86 | 0.80 | 3.79 | 0.80 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.24 | 0.23 | 0.09 | 0.10 | 0.10 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | 1.35 | 1.17 | 1.19 | -2.79 | 1.27 |
Currency in USD
